Detalles de la búsqueda
1.
Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study.
J Hepatol
; 73(2): 231-240, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32234329
2.
Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
Gastroenterology
; 154(4): 874-885, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29174926
3.
Home infusion of intravenous velaglucerase alfa: Experience from pooled clinical studies in 104 patients with type 1 Gaucher disease.
Mol Genet Metab
; 120(1-2): 111-115, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27614581
4.
A multicenter, open-label extension study of velaglucerase alfa in Japanese patients with Gaucher disease: Results after a cumulative treatment period of 24months.
Blood Cells Mol Dis
; 59: 140-7, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27241455
5.
Long-term velaglucerase alfa treatment in children with Gaucher disease type 1 naïve to enzyme replacement therapy or previously treated with imiglucerase.
Mol Genet Metab
; 117(2): 164-71, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26043810
6.
Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.
JPEN J Parenter Enteral Nutr
; 44(4): 697-702, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31423614
7.
Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
Clin Nutr
; 39(8): 2479-2486, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31784300
8.
Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series.
Clin Nutr
; 39(6): 1774-1777, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31522784
9.
Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials.
Therap Adv Gastroenterol
; 13: 1756284820905766, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32341691
10.
Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.
J Clin Endocrinol Metab
; 104(11): 5136-5147, 2019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31369089
11.
Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
Nutr Clin Pract
; 33(4): 520-527, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29761915
12.
Safety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-µg or 50-µg Daily Doses.
Clin Ther
; 39(10): 2096-2102, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28942334
13.
Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions.
Ther Clin Risk Manag
; 8: 15-23, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22298950
14.
Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions.
Ther Clin Risk Manag
; 8: 25-32, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22298951
Resultados
1 -
14
de 14
1
Próxima >
>>